NCT00001729View on ClinicalTrials.gov

Combination Drug Therapy for Patients With Hepatitis C

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

October 31, 1997

Study Completion Date

September 30, 2002

Conditions
Chronic Hepatitis CFibrosisHemolytic Anemia
Interventions
DRUG

Ribavirin

Trial Locations (1)

20892

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda

All Listed Sponsors
lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00001729 - Combination Drug Therapy for Patients With Hepatitis C | Biotech Hunter | Biotech Hunter